Leveron&Nexovas
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 166  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,399 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Methods
 » Results
 » Discussion
 » Conclusion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed142    
    Printed0    
    Emailed0    
    PDF Downloaded5    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2022  |  Volume : 70  |  Issue : 2  |  Page : 623-632

Large Vessel Occlusions By Free Floating Thrombi in Strokes During the COVID-19 pandemic- A Single Center Observational Study


1 Department of Neurology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
2 Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
3 Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
4 Department of Neurosurgery, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
5 Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

Date of Submission06-Jun-2021
Date of Decision06-Nov-2021
Date of Acceptance06-Nov-2021
Date of Web Publication3-May-2022

Correspondence Address:
Dr. Samhita Panda
Department of Neurology, All India Institute of Medical Sciences, Jodhpur, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.344655

Rights and Permissions

 » Abstract 


Background: An increased incidence of systemic macrothrombotic phenomena such as strokes has been observed in moderate and severe COVID. However, strokes have also been increasingly observed in mild COVID, post COVID, or without obvious COVID illness.
Objective: To share our experience with a specific stroke type noted during the COVID pandemic period.
Materials and Methods: A single-center observational study was conducted in Western India from January to December 2020, and data regarding stroke patients admitted under Neurology services were noted. Clinical, laboratory, and radiological characteristics of strokes and subtypes were documented.
Results: A total of 238 stroke patients were admitted in 2020, 76.5% during the COVID pandemic period. Among 153 ischemic strokes, 16.3% and 56.2% had large vessel occlusion (LVO) in pre-COVID and COVID pandemic period, respectively. Of all ischemic strokes, 20.9% (18 patients) and 12% (3 patients) had free floating thrombus (FFT) in the COVID versus pre-COVID period, respectively. Only 44.4% of all FFT patients could be proven SARS-CoV-2 RT-PCR positive while 50% were COVID suspect with surrogate markers of heightened inflammation at time of stroke. All patients were given anticoagulation and average mRS at discharge was 3.1 (range: 1–6) and 1.84 (range: 0–4) at 3-month follow-up in survivors.
Conclusions: This study highlights the presence of FFT causing LVO as a new stroke subtype during the COVID-19 pandemic. With renewed and steeper spike in COVID-19 cases, especially new variants, the resurgence of this stroke subtype needs to be actively explored early in the course of illness to reduce morbidity and mortality.


Keywords: Anticoagulation, COVID-19, free-floating thrombus, ischemic stroke, large vessel occlusion
Key Message: Presence of free-floating thrombi (FFT) in cerebral vasculature has been frequently observed during the COVID-19 pandemic. Active search for FFT should be made in strokes during the pandemic, especially in young patients with multiple territorial infarcts and without risk factors and anticoagulation should be encouraged.


How to cite this article:
Panda S, Tiwari S, Pamnani J, Vegda M, Patel A, Sharma S, Jain S, Patel P, Saroha D, Khera P, Midha N, Garg M, Nag VL. Large Vessel Occlusions By Free Floating Thrombi in Strokes During the COVID-19 pandemic- A Single Center Observational Study. Neurol India 2022;70:623-32

How to cite this URL:
Panda S, Tiwari S, Pamnani J, Vegda M, Patel A, Sharma S, Jain S, Patel P, Saroha D, Khera P, Midha N, Garg M, Nag VL. Large Vessel Occlusions By Free Floating Thrombi in Strokes During the COVID-19 pandemic- A Single Center Observational Study. Neurol India [serial online] 2022 [cited 2022 May 22];70:623-32. Available from: https://www.neurologyindia.com/text.asp?2022/70/2/623/344655




Coronavirus disease (COVID-19), the pandemic declared by the World Health Organization on March 11, 2020 that has shaken the world with its widespread medical, social, and economic ramifications, is still poorly understood. While its prominent symptoms have been respiratory, with influenza-like illness, dyspnea, respiratory failure, and severe hypoxemia, extra-pulmonary manifestations such as diarrhea, renal failure, gastroenteritis, myocarditis, myalgias, and low exercise tolerance have also come to the fore.[1] Reported neurological manifestations initially included ageusia, anosmia, acute hemorrhagic necrotizing encephalopathy, meningoencephalitis, central and peripheral demyelination, and seizures.[1],[2]

However, subsequently increased incidence of strokes (5%–6%) have been reported, more so in moderate to severe COVID.[1],[2],[3],[4],[5] In tandem, increased incidence of pulmonary embolism, deep vein thrombosis, and renal arterial thrombi have also been noted.[6],[7] This has led to the modification of treatment strategies for patients with moderate and severe disease across the world. Although there is profuse literature on stroke in COVID-19, no clear consensus regarding treatment and prevention has emerged. Here, we share the experience at our center with strokes during this period with special reference to a particular subset and describe its characteristic clinico-radiological features, treatment, and outcomes.


 » Methods Top


This study was conducted at a tertiary care center in Western Rajasthan, a desert state in India. It was an ambispective study (retrospective till June 2020 and prospective thereafter), approved by the Institutional Ethics Committee (AIIMS/IEC/2020-21/3038). Data were collected for all stroke patients admitted under the department of Neurology from January to December 2020. Details pertaining to demographic, clinical characteristics, disease progression, risk factors, laboratory evaluation, neuroimaging features, treatment, and outcomes were collected. Patients were categorized as ischemic stroke, hemorrhagic stroke, and venous strokes based on initial imaging [computed tomography (CT) or magnetic resonance imaging (MRI brain)]. Patients were subclassified into strokes with onset before the official outbreak of COVID-19 in India and those thereafter. This was done with a view to analyze the change in stroke profile across the pandemic.

Radiological evaluations such as angiography, venography, and perfusion studies were done as per stroke type. For ischemic strokes, non-contrast CT head and CT angiography (CTA) was done to define the core of infarct and cerebral blood flow at baseline and follow-up. CTA was performed to include the aortic arch upwards. CT perfusion studies were added for patients who presented within 24 h of ictus to assess perfusion deficits. The radiological findings of all patients were carefully reviewed by the neuroradiologists (S.T. and J.P.).

All relevant hematological and biochemical investigations for stroke were done with evaluation for thrombophilic states wherever possible or as indicated. Screening with electrocardiography, transthoracic echocardiography, and arterial Doppler of limbs was done routinely, and Holter monitoring as clinically indicated. Treatment was accorded as per the standard protocol of stroke management at the institute, which is as per National Stroke guidelines and recommendations during the COVID pandemic.[8] The best possible medical, surgical and endovascular treatment was offered depending on stroke duration, type, and clinical situation.


 » Results Top


The first case of COVID-19 in India was reported on January 30, 2020 and a country-wide and state-wide lockdown was rigorously implemented from March 25, 2020. Our institution is located in Jodhpur, a city in the state of Rajasthan, India having a catchment area including southern and western parts of this western border state and neighboring states of Gujarat, Madhya Pradesh, Haryana, and Maharashtra. It is a COVID-dedicated hospital but also continues to admit non-COVID patients. The first case of COVID-19 was reported in Jodhpur on March 21, 2020. The total number of stroke patients admitted under the Neurology services from January to December 2020 was 238, of which there were 56 (38 ischemic, 15 hemorrhagic, and three venous) strokes before lockdown and 182 (115 ischemic, 49 hemorrhagic, and 18 venous) during the COVID pandemic period spanning 9 months (April–December 2020).

Among all ischemic strokes, 25 and 86 patients had large vessel occlusion (LVO), nine and 18 patients had small vessel occlusion (SVO), whereas four and one patient had cardioembolic stroke in the pre-COVID lockdown period and COVID pandemic period, respectively.[9] The in-hospital mortality was 5.4% in the pre-lockdown period and 11.5% in the COVID pandemic period.

Out of the 153 ischemic stroke patients, 21 patients (13.7%) had free-floating thrombus (FFT) in the vessels, 18 of whom were admitted between May and December 2020. An FFT was defined on CTA as a filling defect within the vessel lumen completely surrounded by contrast on at least two contiguous axial source images, producing the classical “donut sign.”

The detailed clinical and risk factor characteristics of these patients with FFT are elucidated in [Table 1]. There were 14 male and four female patients with a mean age of 51.6 (29–76 years). Seven patients had stroke in young, that is, were ≤45 years. Mean NIHSS at stroke onset was 15.2 (range: 3–25), and mean mRS was 4.5 (range: 3–5). Seven patients (38.9%) had been respiratory features of COVID-19, of which five had stroke in the second week, 4–10 days after testing positive for COVID-19. Traditional vascular risk factors for stroke were absent in seven patients and four had hypertension alone.
Table 1: Clinical characteristics of stroke with floating thrombus

Click here to view


Hematological and biochemical profile suggesting heightened inflammatory state (raised ESR, hs-CRP, IL-6, ferritin) was noted in 14 patients (77.8%). Increased D-dimer levels were seen in ten patients, hyperhomocysteinemia in ten patients, MTHFR mutations in four patients, antiphospholipid antibody syndrome in one patient, while none had evidence of vasculitis. Eight (44.4%) tested positive for COVID-19 by nasopharyngeal swab RT-PCR, while seven were negative and three were not tested (as presented earlier in the pandemic when governmental indications for testing included influenza-like illness or high-risk contacts). Among the remaining without PCR-proven COVID-19, nine (50%) had surrogate markers of heightened inflammatory state and/or increased D-dimer, one of which had additional radiological features of COVID-19-specific lung involvement [Table 2].
Table 2: Radiological characteristics of stroke with floating thrombus

Click here to view


Radiological features of infarct location and size as well as vessel and thrombus characteristics are given in [Table 2]. Out of all patients with LVO, 18.9% had FFT from January to December 2020. Of these, 20.9% and 12% had FFT in the COVID pandemic period versus the pre-COVID period, respectively [Figure 1]. Of stroke with FFT during COVID pandemic period, six had ASPECTS ≥7 on initial CT while ten had ASPECTS ≤6. Seven patients had multiple embolic infarcts in one or more arterial territories. On CTA, LVO was noted in 13 and five patients in anterior and posterior circulation, respectively. Multiple sites for FFT were seen in four patients while eight patients had thrombi in proximal vessels, that is, aortic arch, subclavian, brachiocephalic, or proximal common carotid artery [Figure 2]. One patient additionally had limb ischemia with gangrene of digits [Figure 3]. The presence of multiple arterial territorial infarcts and proximal arterial thrombi was a peculiar radiological feature in LVO with FFT.
Figure 1: A 54-year-old male [Case 13: RT-PCR-proven COVID-positive] presented with a complaint of right-sided weakness for 12 h. The axial non-contrast head CT image (a) shows acute infarct in the left MCA territory. The axial (b), sagittal (c), and coronal (d) contrast CT angiography images show central filling defect, floating thrombus (white arrow) in the left ICA distal to bifurcation of CCA with a small component of it attached to posterior wall of ICA. The patient succumbed to the illness

Click here to view
Figure 2: A 58-year-old COVID-positive man [Case 15] with right-sided hemiparesis. Axial HRCT thorax image (a) shows bilateral peripheral ground glass opacities typical of COVID-19 infection. Axial CT angiography images, caudal to cranial (b, c, d) show central filling defects in multiple vessels involving aortic arch (white arrow), left subclavian artery (arrow-head), left ECA (dashed arrow) and right ICA (rounded arrow). Follow-up imaging shows complete resolution of free-floating thrombi (e and f)

Click here to view
Figure 3: A 42-year-old female [Case 17; COVID-positive] presented with altered sensorium, pulseless left upper-limb with (a) digital gangrene. Diffusion-weighted MR imaging revealed multiple acute infarcts in right lateral thalamus, parieto-occipital cortex (posterior cerebral artery territory), brain stem, and bilateral cerebellar hemispheres (b and c). CT angiography (d and e) revealed eccentric hypodense filling defects, that is, FFT in left subclavian extending to ipsilateral vertebral origin (white arrow head)

Click here to view


Six patients in this group presented within the window period and were thrombolysed while one underwent mechanical thrombectomy (MT). All patients were given anticoagulation either immediately or 24 h after intravenous thrombolysis (IVT). Unfractionated heparin (UFH) or low molecular weight heparin (LMWH) was given and shifted to oral anticoagulants after 7–10 days. Five patients (27.7%) with FFT had a massive volume of infarcts involving complete MCA, ICA, or bilateral vertebrobasilar territories and rapidly deteriorated with impending herniation, three of whom were surgically treated with decompression craniectomy. All five patients in this subgroup could not be salvaged despite the best medical and surgical therapy and died [Figure 1] and [Figure 3]. Average mRS at discharge was 3.1 (range: 1–6), and mean mRS for the survivors (13 patients) at 3 months was 1.77 (range: 0–4).


 » Discussion Top


This observational single-center study from western India has brought to fore a specific stroke causation during the COVID pandemic comprising FFT in the large vessels supplying cerebral vasculature. A total of 9.9% of all stroke types (18 patients) and 15.6% of ischemic strokes during the COVID pandemic period had FFT. Among ischemic strokes, those due to LVO was the predominant subtype (74.8%) reporting to the emergency room (ER) for neurological management. This could be due to inherent referral bias and patient preference bias. Patients with SVO may not have severe enough strokes and families either may have refused admission or did not seek to attend the ER due to treatment hesitancy for fear of contracting COVID-19 infection in the hospital. Other studies on stroke patterns during the pandemic have also shown a high incidence of LVO.[4],[5] Interestingly, more than one-fifth of LVO had FFT during the pandemic period, thereby emphasizing a higher predilection for it.

An FFT consists of friable thrombi that are either completely detached or partially attached to underlying vessel with one end free.[10] The FFT tends to move in an arc-like pendulous manner with each cardiac cycle while remaining attached and is prone to break-away fragments. It may be formed due to underlying ulcerated atherosclerotic plaques and other vessel wall pathology such as dissection, trauma, or other cause for endothelial discontinuity.[10],[11],[12] In addition, thrombophilic states such as malignancy, pregnancy, antiphospholipid syndrome, prothrombotic predisposition due to genetic mutations, and sepsis may contribute. Rarely, FFT may occur with a non-aneurysmal uninvolved vessel wall or without known etiology.

FFT is a potentially life-threatening situation that can predispose to ischemic strokes as well as peripheral and pulmonary embolism. Previous reports suggest an increased frequency of FFT in the aorta where it can manifest in 73% with embolic events such as distal embolism and limb ischemia.[13] FFT in cerebrovascular circulation is invariably symptomatic with neurological manifestations.[11],[12],[14] However, FFT has rarely been reported in cerebral ischemic stroke with an estimated incidence of 0.05%–1.45%.[10],[11],[12] On the contrary, our study showed higher frequency during the COVID pandemic with intraluminal thrombi in large extracranial as well as intracranial vessels of anterior and posterior circulation and/or immediate proximal vasculature from aortic arch upwards (44.4%) posing a high risk. Interestingly, this and multiple thrombi (22.2%) predisposed to recurrent strokes in some patients even while on optimum antiplatelets, and transient ischemic attacks (TIAs) or minor strokes with stuttering course preceding the acute event in 50% [Table 1], thereby emphasizing need for early detection.

Analysis of risk factors showed a single risk factor in four patients while seven had none. In the pre-COVID era, advanced age and multiple cardiovascular risk factors predisposed to FFT, especially carotid plaque instability and underlying vessel wall pathology.[11],[12],[14],[15] In addition, the heterogeneous group of hematological disorders presenting as cerebral ischemic events needs to be ruled out, especially in young strokes.[16] In the present pandemic, a proinflammatory environment, endothelial dysfunction, and hypercoagulable state caused by COVID-19 may be deemed responsible for thrombus formation.[15],[17],[18] Increased thrombotic events such as pulmonary thromboembolism, limb ischemia, DVT, and strokes (31%) have been noted during the pandemic and established in autopsy studies.[4],[6],[7],[19],[20] However, the exact pathophysiology and complexity of the procoagulant state related to COVID-19 are yet to be clearly elucidated. A dangerous combination of hyper-inflammatory state with associated tissue hypoxia, prolonged immobilization, and diffuse intravascular coagulation play an instrumental role in some way. SARS-CoV-2 infection is known to trigger a cascade of inflammation with the release of mediators such as IL-6, hs-CRP, and surrogate markers such as ferritin.[17] An increased D-dimer level has also been noted accompanying the cytokine storm in COVID-19.[18]

Mohamud et al.[21] suggested the interplay between increased thrombogenicity and plaque inflammation ultimately leading to plaque-rupture with thrombosis. However, the severity of stroke in COVID-19 may not be directly associated with carotid atherothrombosis as seen in 50% of our patients, where even mild atherosclerotic disease served as site for acute thrombus formation. Most reports with FFT in COVID patients were in patients without atherosclerosis.[22],[23],[24] Additionally, these thrombotic episodes occurred despite receiving anticoagulant therapy in some cases.

While 44.4% of FFT were found to be COVID-PCR positive, 38.9% had active COVID infection and an additional 50% had surrogate inflammatory markers supporting suspected COVID. An unprecedented high number of patients with FFT seen at our center (20.9% of all LVO) during the ongoing pandemic raises various questions. In addition, the true COVID status of those testing PCR-negative in our subset is open to debate as a negative RT-PCR nasopharyngeal swab test with a detection rate of 65% is insufficient to rule out COVID-19.[25] Thus, although a direct cause and effect relationship with COVID-19 infection and FFT as cause of stroke cannot be established in the present study, high frequency of a particular event repeating itself over a short time period definitely raises concerns. This may eventually be clearer as the pandemic evolves. However, this may suggest the possibility of thrombogenic state induced by symptomatic as well as asymptomatic SARS-CoV-2 infection during the ongoing pandemic.

To date, consequences of FFT in COVID-19 have been sparingly reported. While COVID-related aortic FFT presenting with limb ischemia and pulmonary symptoms have been reported, only three patients were detected during CTA screen for cause of stroke without FFT in the cerebral vasculature.[22],[23],[24] The present study is the first report of documented FFT in cerebral vasculature in strokes noted during the COVID-19 pandemic.

The management of FFT-related stroke in COVID-19 needs to be aggressive and comprises medical, surgical, endovascular, or a combination of modalities. While recently published guidelines for stroke management in COVID-19 suggest otherwise,[26] all patients with FFT reported here underwent anticoagulation irrespective of initial IVT/MT given. Anticoagulation was started immediately or after 24 h if thrombolysed. Published literature has shown that anticoagulation with or without antiplatelets led to complete dissolution of FFT in 86% when treated for 2–24 weeks without significant difference in outcome compared with the surgical arm.[11] Though no randomized trials are there to support either therapeutic modality yet, early medical therapy may suffice in most cases without the need for emergent surgical or endovascular therapy.

Compared to the high mortality of up to 38% in COVID strokes, all patients improved remarkably from mean mRS at admission of 4.5 to mean mRS at discharge of 3.1.[1],[3] Only 27.8% died, with no age predilection (29–71 years), majority with no or single risk factor but having complete territorial malignant infarcts with brain edema not responding even to surgical decompression. Of the survivors, 69.2% had mRS of ≤2 at 3-month follow-up. The authors' experience with anticoagulation in stroke with this subset of ischemic stroke with FFT has been very encouraging.[26] A rapid improvement in physical deficits in a short period of time and near-complete resolution of floating thrombus component augers well with a good outcome and further points to inflammatory origin and transient nature of thrombus.


 » Conclusion Top


The presence of FFT in the cerebral vasculature has been frequently observed in ischemic strokes during the COVID-19 pandemic. Active search for FFT in COVID positive or suspect patients, especially in young patients, without significant risk factors, multiple territorial infarcts with/without significant influenza-like illness, as well as assessment for factors contributing to thrombophilia need to be explored. Use of anticoagulation is encouraging, with good stroke outcomes as early as 1–2 months. With the renewed and steeper spike in COVID-19 cases, especially with new variant mutations, the resurgence of this finding needs to be actively explored early in the course of illness to reduce morbidity and mortality.

Acknowledgements

The authors would like to thank the ICMR- National Centre for Disease Informatics and Research, Bengaluru for funding the ongoing stroke registry at our center, a subset of which was studied in the present paper. We would also like to thank the Administration of All India Institute of Medical Sciences, Jodhpur, nursing staff, and healthcare workers who provided their support, as well as patients who were assessed in the course of the study.

Financial support and sponsorship

ICMR- National Centre for Disease Informatics and Research, Bengaluru, India.

Conflicts of interest

There are no conflicts of interest.



 
 » References Top

1.
Zhou F, Yu T, Du R, Fan G, Liu Z, Xiang J, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395:1054-62.  Back to cited text no. 1
    
2.
Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020;413:116832.  Back to cited text no. 2
    
3.
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study. Stroke Vasc Neurol 2020;5:279-84.  Back to cited text no. 3
    
4.
Fifi JT, Mocco J. COVID-19 related stroke in young individuals. Lancet Neurol 2020;19:713-5.  Back to cited text no. 4
    
5.
Goldberg MF, Goldberg MF, Cerejo R, Tayal AH. Cerebrovascular disease in COVID-19. AJNR Am J Neuroradiol 2020;41:1170-2.  Back to cited text no. 5
    
6.
Klok FA, Kruip MJ, van der Meer NJ, Arbous MS, Gommers DA, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145-7.  Back to cited text no. 6
    
7.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020;75:2950-73.  Back to cited text no. 7
    
8.
Bhatia R, Sylaja PN, Srivastava P, Khurana D, Pandian JN, Suri V, et al. Consensus Statement-Suggested recommendations for acute stroke management during the COVID-19 pandemic: Expert group on behalf of the indian stroke association. Ann Indian Acad Neurol 2020;23(Suppl 1):S15-23.  Back to cited text no. 8
    
9.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35-41.  Back to cited text no. 9
    
10.
Arning C, Herrmann HD. Floating thrombus in the internal carotid artery disclosed by B-mode ultrasonography. J Neurol 1988;235:425-7.  Back to cited text no. 10
    
11.
Bhatti AF, Leon LR Jr, Labropoulos N, Rubinas TL, Rodriguez H, Kalman PG, et al. Free-floating thrombus of the carotid artery: Literature review and case reports. J Vasc Surg 2007;45:199-205.  Back to cited text no. 11
    
12.
Roy M, Roy AK, DeSanto JR, Abdelsalam M. Free floating thrombus in carotid artery in a patient with recurrent strokes. Case Rep Med 2017;2017:4932567.  Back to cited text no. 12
    
13.
Karalis DG, Chandrasekaran K, Victor MF, Ross JJ Jr, Mintz GS. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 1991;17:73-8.  Back to cited text no. 13
    
14.
Ferrero E, Ferri M, Viazzo A, Labate C, Pecchio A, Berardi G, et al. Free-floating thrombus in the internal carotid artery: Diagnosis and treatment of 16 cases in a single center. Ann Vasc Surg 2011;25:805-12.  Back to cited text no. 14
    
15.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endothelitis in COVID-19. Lancet 2020;395:1417-8.  Back to cited text no. 15
    
16.
Arboix A, Jimenez C, Massons J, Parra O, Besses C. Hematological disorders: A commonly unrecognized cause of acute stroke. Rev Hematol 2016;9:891-901.  Back to cited text no. 16
    
17.
Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020;18:1738-42.  Back to cited text no. 17
    
18.
Han H, Yang L, Liu R, Liu F, Wu F-L, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020;58:1116-20.  Back to cited text no. 18
    
19.
Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A, White A, Anderson AS, Chilton R. The role of anticoagulation in COVID-19-induced hypercoagulability. Curr Cardiol Rep 2020;22:53.  Back to cited text no. 19
    
20.
Wichchman D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann Intern Med 2020;173:268-77.  Back to cited text no. 20
    
21.
Mohamud AY, Griffith B, Rehman M, Miller D, Chebl A, Patel SC, et al. Intraluminal carotid artery thrombus in COVID-19: Another danger of cytokine storm? Am J Neuroradiol 2020;41:1677-82.  Back to cited text no. 21
    
22.
de Carranza M, Salazar D-E, Troya J, Alcázar R, Peña C, Aragón E, et al. Aortic thrombus in patients with severe COVID19: Review of three cases. J Thromb Thrombolysis 2021;51:237-42.  Back to cited text no. 22
    
23.
Silingardi R, Gennai S, Migliari M, Covic T, Leone N. Acute limb ischemia in COVID-19 patients: Could aortic floating thrombus be the source of embolic complications? J Vasc Surg 2020;72:1152-3.  Back to cited text no. 23
    
24.
Gomez-Arbelaez D, Ibarra-Sanchez G, Garcia-Gutierrez A, Comanges-Yeboles A, Ansuategui-Vicente M, Gonzalez-Fajardo JA. COVID-19-related aortic thrombosis: A Report of four cases. Ann Vasc Surg 2020;67:10-3.  Back to cited text no. 24
    
25.
Zitek T. The appropriate use of testing for COVID-19. West J Emerg Med 2020;21:470-2.  Back to cited text no. 25
    
26.
Qureshi AI, Abd-Allah F, Al-Senani F, Aytac E, Borhani-Haghighi A, Ciccone A, et al. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. Int J Stroke 2020;15:540-4.  Back to cited text no. 26
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow